NCT01863654View on ClinicalTrials.gov

Bioequivalence Study of Montelukast 5 mg Chewable

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 16, 2010

Primary Completion Date

May 26, 2010

Study Completion Date

May 26, 2010

Conditions
Asthma
Interventions
DRUG

Montelukast 5 mg chewable tablets

Reference product

DRUG

Montelukast 5 mg chewable tablets

Test product

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01863654 - Bioequivalence Study of Montelukast 5 mg Chewable | Biotech Hunter | Biotech Hunter